Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-12-23 Purchase |
2022-12-28 4:05 pm |
Oncocyte Corp | OCX | Gutfreund John Peter Director |
75,000 | $0.3297 | $24,728 | 75,000 (Indirect) |
View |
| 2022-08-15 Purchase |
2022-08-17 8:19 pm |
Oncocyte Corp | OCX | Gutfreund John Peter Director |
25,000 | $0.93 | $23,250 | 80,000 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-06-30 Other |
2023-07-03 6:00 pm |
N/A 2027-04-19 |
Oncocyte Corp | OCX | Gutfreund John Peter Former Director Director |
6,649,775 | $0 | 7,941,914 (Indirect) |
View |
| 2023-04-03 Option Award |
2023-04-05 9:30 pm |
N/A N/A |
Oncocyte Corp | OCX | Gutfreund John Peter Director |
1,705,000 | $0.3544 | 1,790,000 (Direct) |
View |
| 2022-08-15 Option Award |
2022-08-17 8:19 pm |
N/A 2032-08-15 |
Oncocyte Corp | OCX | Gutfreund John Peter Director |
55,000 | $0 | 80,000 (Direct) |
View |
Ownership |
2022-08-08 4:28 pm |
N/A N/A |
Oncocyte Corp | OCX | Gutfreund John Peter Director |
0 | $0 | 6,650,951 (Indirect) |
View |